Jackie A. Lavigne

Catechol-O-methyltransferase polymorphism is not associated with ovarian cancer risk.

Julie E. Goodman, Jackie A. Lavigne, Jan G. Hengstler, 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Increased mitochondrial superoxide production in rat liver mitochondria, rat hepatocytes, and HepG2 cells following ethinyl estradiol treatment.

J. Yager, M. Trush, J. Lavigne, 1999, Toxicological sciences : an official journal of the Society of Toxicology.

An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer.

D. Bell, J. Yager, K. Helzlsouer, 1997, Cancer research.

COMT genotype, micronutrients in the folate metabolic pathway and breast cancer risk.

J. Yager, K. Helzlsouer, P. Strickland, 2001, Carcinogenesis.

Catechol-O-methyltransferase polymorphism is not associated with ovarian cancer risk.

J. Yager, J. Hengstler, K. Helzlsouer, 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.